Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBT to Determine Exocrine Pancreatic Function and Related QOL in Chronic Pancreatitis
NCT07418593Phase 4Recruiting
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 4, randomised trial in exocrine pancreatic insufficiency (EPI) (6 arms). Primary endpoints: Prevalence of PERT-responsive fat malabsorption at 2 weeks and Change from baseline in the PROMIS 29+2 at 8 weeks. Started Apr 2026; status: recruiting.
02
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT07418593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418593.